Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02729428 · ClinicalTrials.gov registry record
MRI Biomarkers and Exercise
A clinical trial, sponsored by University of Wisconsin, Madison.
- Completed
- Registry status
- 71
- Enrollment target
NCT02729428: Completed study, sponsored by University of Wisconsin, Madison.
NCT02729428 is a clinical trial that has completed, run by University of Wisconsin, Madison. The registered enrollment target is 71 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02729428 has completed, sponsored by University of Wisconsin, Madison.
- COMPLETED
- Registry status
- 71 participants
- Enrollment target
Study Summary
The overall goal of observational study is to examine the age-related and habitual exercise training status-related differences in structural and functional changes in the human brain, detected by magnetic resonance (MR) imaging.
Primary Outcome
Utilize an MRI to measure brain volume when participant is at rest
Interventions
- DEVICE MRI
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 71 participants |
| Start Date | 2016-04 |
| Est. Completion | 2019-04 |
What the finished NCT02729428 record still lists
NCT02729428 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 71 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which MRI is the first listed.
NCT02729428 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02729428 about?
NCT02729428 is a clinical study titled "MRI Biomarkers and Exercise". The overall goal of observational study is to examine the age-related and habitual exercise training status-related differences in structural and functional changes in the human brain, detected by magnetic resonance (MR) imaging.
What is the current status of trial NCT02729428?
This trial is currently completed. The enrollment target is 71 participants. The study started on 2016-04. Estimated completion is 2019-04.
What interventions are being tested in trial NCT02729428?
The interventions under investigation include: MRI (DEVICE).
Who is sponsoring clinical trial NCT02729428?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05452889 · 71 participants · Early Phase 1
PET Image in PAH Patients
- NCT05766943 · 71 participants · NA
Reduction of Myopotential Interference With Smart Pass in S-ICD Patients
- NCT06229678 · 71 participants · Early Phase 1
Ketones, SGLT2, HFrEF
- NCT06377566 · 71 participants · Phase 2
A Study of BV-AVD in People With Bulky Hodgkin Lymphoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia